论文部分内容阅读
以S·罗申贝格为代表的美国国立癌症研究所(NCI)的科学家们提出了一种治疗癌症的新方法。已知在生体的防御组织中称为LAK的淋巴球有抗癌活性,不过通常仅存在极微量。罗申贝格取出患者的淋巴球并将之置于可促进LAK细胞分裂、增殖的物质间白氨酸Ⅱ中。然后,再将少量间白氨酸Ⅱ和淋巴球反馈给患者。将上述方法用于采取传统方法治疗无效的25人后,其中1人的癌细胞完全萎缩,10人的部分萎缩。
Scientists at the National Cancer Institute (NCI), represented by S. Rothsenberg, have proposed a new method of treating cancer. It is known that a lymphocyte called LAK in the defensive tissue of a living body has anticancer activity, but usually only exists in a very small amount. Roschenberg took out the patient’s lymphocytes and placed it in the interleukine II, which promotes the division and proliferation of LAK cells. Then, a small amount of interleukine II and lymphocytes were fed back to the patient. After the above method was applied to 25 people who failed conventional treatment, one of the cancer cells completely shrank, and 10 of them partially shrank.